Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0001209191-23-020244

EVP & Chief Financial Officer sold 2,000 shares at an average $296.39 ($592,786)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

WAGNER CHARLES F JR · EVP & Chief Financial Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2023-03-17 Sale : show line 1 in the form 10b5-1 −360 $294.52 $106,027 53,019 D
2023-03-17 Sale : show line 2 in the form 10b5-1 −784 $295.43 $231,617 52,235 D
2023-03-17 Sale : show line 3 in the form 10b5-1 −240 $296.30 $71,112 51,995 D
2023-03-17 Sale : show line 4 in the form 10b5-1 −360 $298.09 $107,312 51,635 D
2023-03-17 Sale : show line 5 in the form 10b5-1 −240 $299.58 $71,899 51,395 D
2023-03-17 Sale : show line 6 in the form 10b5-1 −16 $301.13 $4,818 51,379 D
Open-market sales · 2,000 sh · avg $296.39 · $592,786
Loading xslF345X04/doc4.xml…